to view your mail
U.S. Markets closed
Regulus Therapeutics Inc. (RGLS)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
At close: 4:00PM EST
864 reactions on $RGLS conversation
Sign in to post a message.
Third quarter report out, and it's a very positive report. Regulus is delivering on its promises and achieving its goals. Looking forward to their continued progress.
$1 in 1 month
Is there any life left in this stock?
Already $0.58, up more than 20% in after-hours trading. I'm so glad I already have mine.
I’m wondering if Management ever looks at history and performance on this stock . It’s been overdue for CEO to step down and have someone with knowledge to run this company if anything left
This week should be a good one for RGLS. Time to move again. Just need a little more volume. Do your DD and follow Denner. GO$ RGLS$GO
Well one week off. The run is coming just have to have patience! Go RGL$
fda approved news
And add a new pipeline.
Obvious pattern. More than 100 percent rise at the end.
Target price $2+ company of only 22M
healthcare seems to be leading the markets today
Things are looking to become quite difficult for the company in the next 6 months. With data for the phase 2 study in alport probably only coming in 2019 or late 2018, and the phase 1 data in ADPKD being completed in Q3 (so data likely in late Q3- Q4), there isn't much in the way of near term catalysts to lift the share price. This isn't good because, per their SEC fillings, they just received notice from NASDAQ that they could lose their placement on the NASDAQ market if they do not comply with the 1.00 share price minimum within the next 180 days. 180 days from now is around the end of October, so the best case scenario is for very positive phase 1 data to be released that lifts the share price considerably.
Beyond this, their cash position isn't very strong either. They had 60 million at the end of 2017, and guided for 12m/quarter cash burn. Their cash position is rapidly declining, so they will need to find a way to raise money. A dilution at these depressed share prices would be pretty devastating, and would probably guarantee that they would no longer be able to comply with NASDAQ's minimum price by the end of October. They could take on additional debt, but they already took out debt last year, so it may be difficult to take on anymore additional debt.
The only way I see them making it out of this situation is a timely partnership that offers high upfront cash or a reverse stock split followed by dilution. Management alluded to interested partners, but I'm not sure they would be able to get a deal good enough to save them considering how early stage their pipeline is.
I'm assuming they will try to deal with this before the phase 1 data reads out, so that they don't have to rely on it to survive as a company.
I'm interested in the science of this company, but I'm going to wait on the sidelines to see how the next 6 months plays out. I'm hoping to get in after these issues are dealt with. This should be around the time that the phase 2 data is released.
Good luck to any longer currently holding.
This is very bullish. Hold your shares and buy more.
Time to buy?
hope above 4 today
It can’t keep dropping! Ones the news for phases coming out, this stock will fly! Be patient my friend!
NEA management, biotechnology value fund, Sanofi and steve cohen's family office. they've all bought into RGLS in the past quarter before biopsy data. the share price has been downtrending because of a delay in the data but in the long term, this doesnt change much. big boys are here and they clearly see long term value in RGLS. this could be a major gem.
mkt cap 18 millions, company cash 23,4 !!!
I think this is going Up twice or triple Soon ..
Here's another prediction. Delisting notice coming again only to eventually recover above $1. Just played out within the last year. Now it's doing the same thing again with a different CEO.
Americans 'are just tired of COVID,' and the results are disastrous
We’re seeing people booking tours that are distanced with smaller groups: CEO
Yahoo Finance Video
NFL Raiders Muni-Financed Stadium Debt Shows Sign of Strain
Advertise With Us
© 2020 Verizon Media. All rights reserved.
About Our Ads
Discover new investment ideas by accessing unbiased, in-depth investment research